Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

26 mars 2018

05:52
D'importantes étapes ont été franchies dans la mise au point de ZEMY, solution compagnon digitale développée depuis 2015 par Roche Pharma France en partenariat avec Voluntis afin d'améliorer l'accompagnement des patientes atteintes de cancer du sein....

05:42
Today, Voluntis and Roche Pharma France announced that important milestones have been reached in the development of ZEMY, a digital therapeutic developed by Roche Pharma France in partnership with Voluntis since 2015. ZEMY aims to improve care...

04:00
Unique nerve mapping technology for renal denervation (RDN) procedure provides more effective treatment for resistant hypertension  Pythagoras Medical, a cutting edge medical device company established by Rainbow Medical, Israel's premier...

04:00
In collaboration with the SepNet Critical Care Trials Group, a new analysis of 1089 patients with sepsis and septic shock across 33 German Intensive Care Units was recently published in Critical Care. The biomarker, mid-regional proadrenomedullin...

03:00
Biohaven Pharmaceutical Holding Company Ltd. today announced positive top-line results from both of its two Phase 3 clinical trials (BHV3000-301 and BHV3000-302) of rimegepant (formerly known as BHV-3000), an oral CGRP receptor antagonist for the...

02:00
Allecra Therapeutics, a biopharmaceutical company dedicated to the development of novel antibiotics for the treatment of drug resistant bacterial infections, today announced positive top-line results from the Phase 2 study of its lead antibiotic...


23 mars 2018

19:30
Arena Pharmaceuticals, Inc. today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, will present a corporate update at the 17th Annual Needham Healthcare Conference on Tuesday, March 27 at 3:00 p.m. EDT.  The...

14:00
- First allogeneic stem cell therapy to receive central marketing authorization approval in Europe  - Alofisel offers a new treatment option for patients who do not respond to current available therapies and may be subject to numerous invasive...

09:55
CSL Behring, a global biotherapeutics leader, today announced the initiation of the AEGIS-II (ApoA-I Event reducinG in Ischemic Syndromes II) clinical trial and the first patient enrollment. The clinical trial will evaluate the efficacy and safety of...

09:40
A white paper published today by leaders in clinical research for lupus provides actionable proposals for improving lupus treatment trials and advances persuasive evidence for the U.S. Food and Drug Administration (FDA) to consider in support of new...

08:44
Amgen today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to include a new indication in the Repatha® (evolocumab) label for adults with established...

08:41
Amgen and Allergan plc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of ABP 980, a biosimilar to Herceptin®...

08:07
Researchers from the Los Angeles Biomedical Research Institute (LA BioMed) and the University of Washington announced the results of a study, at the Endocrine Society's annual meeting this week, showing that an experimental oral male contraceptive...

07:00
The bio-med company Alpha Tau Medical, which developed a highly effective and conformal treatment for cancer, successfully held its first international conference last week with over 200 oncologists from leading medical centers around the world....

06:30
Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced publication of an article that demonstrated the Company's proprietary ADAPT Biotargeting Systemtm (ADAPT)...


22 mars 2018

19:45
Novartis today announced that the full results from the Phase III EXPAND study of oral, once-daily siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS) were published in the peer-reviewed journal The Lancet. These pivotal results...

15:35
United Neuroscience, Ltd., (UNS), today announced that it has entered a research collaboration agreement with the Ronald Melki laboratory at the French National Center for Scientific Research (CNRS) to investigate applications of the United...

15:00
Over a 10-year period, control of three key cardiovascular risk factors improved faster for Kaiser Permanente diabetes patients in Northern California than in the rest of the United States, according to research published today in the American...

14:52
A fingerprint test published today in AACC's Clinical Chemistry journal can tell whether someone has taken heroin or cocaine, and accurately distinguishes between drug users versus individuals who were exposed to drug residue in the environment. This...

10:52
A protein that helps regulate the body's inflammatory system appears to play a critical role in causing kidney damage in patients with lupus and could be a target for future treatments for autoimmune disease, a new study has found....

10:00
The big toe plays a crucial role in standing, walking and many other daily activities. It makes it possible for humans to walk and run upright, and it absorbs forces equal to nearly twice a person's body weight when walking. With all that the big toe...

09:32
University Professor of Applied Physics Stephen Arnold and his team at the New York University Tandon School of Engineering have made a discovery that could lead to Star Trek-like biosensor devices capable of flagging the barest presence in blood of...

09:30
As part of its mission to accelerate the development of urgently needed treatment breakthroughs for Parkinson's disease (PD), The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces a program investigating the pathogenesis of...

09:00
Array BioPharma Inc. today announced that detailed results of its pivotal Phase 3 COLUMBUS trial for the treatment of patients with BRAF-mutant advanced, unresectable or metastatic melanoma were published in The Lancet Oncology. In the analysis of...

09:00
DiscGenics, Inc., a clinical stage regenerative medicine company focused on developing cell therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced it has presented results from two...

08:45
AbbVie , a global research and development-based biopharmaceutical company, today announced that after consulting with the U.S. Food and Drug Administration (FDA), it will not seek accelerated approval for Rova-T in third-line relapsed/refractory...

08:00
Exosome Sciences, Inc., a diagnostic subsidiary of Aethlon Medical, Inc. , today announced the initiation of an Institutional Review Board (IRB) approved protocol for a research study involving retired NFL players and a data-supported biomarker...

06:00
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the European Commission, acting...

03:50
Alligator Bioscience , a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that the Annual Report 2017 is available at the company website www.alligatorbioscience.com. This information...

03:27
BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors as a potential cornerstone of combination cancer therapy, announces that the Company will be presenting an overview of the three...


21 mars 2018

17:05
Scientists at the Regeneron Genetics Center, along with investigators at Geisinger, have discovered a gene variant associated with a significant reduction in the risk for chronic liver disease, paving the way for potential new treatment options,...

16:40
Edwards Lifesciences Corporation , the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that enrollment is complete in the computed tomography (CT) imaging sub-study within the...

14:00
Avelas Biosciences, Inc., a clinical stage oncology-focused platform technology company that is developing products to advance a new standard-of-care for cancer surgery and therapeutic intervention, today announced that Carmine N. Stengone, President...

12:15
Researchers have identified a new ALS gene: KIF5A. This important gene discovery, funded by The ALS Association through ALS Ice Bucket Challenge donations, will help researchers understand ALS disease pathways and represents a potential new ALS...

10:29
U.S. Stem Cell, Inc. , a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has published in the scientific literature that it has successfully demonstrated a 99...

10:08
Turning sorrow into action, The Harry T. Mangurian Jr. Foundation, whose namesake died from acute myeloid leukemia (AML), continues to fuel The Leukemia & Lymphoma Society's (LLS) ambitious attack on this deadly blood cancer.  Specifically, with the...

09:00
Processa Pharmaceuticals, Inc. announced today that, as agreed in the asset purchase of Promet Therapeutics, LLC, Processa has been assigned the license for CTP-499 upon Promet's exercising of the exclusive option to license in CTP-499 from Concert...

09:00
AbbVie , a research and development-based global biopharmaceutical company, and the International Myeloma Foundation (IMF) today announced they have entered into a collaboration to conduct a landmark retrospective chart review study to better...

09:00
Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singulex cTnI assay and Single Molecule Counting technology can independently predict moderate and severe coronary disease (CAD), suggesting its clinical...

08:11
BioArctic AB (publ) announced today that the company has received approval by the Norwegian Medicines Agency (NOMA) departments for medicinal products and medical device and the local ethics committee for inclusion of Norwegian patients in...

08:00
Regen BioPharma Inc. and has been methodically optimizing small molecules that bind to, and activate, the NR2F6 nuclear receptor. The process is close to completion, with the primary and back up compounds being readied for final pre-clinical mouse...

08:00
AOBiome Therapeutics ("AOBiome"), a clinical-stage life sciences company advancing patented microbiome-targeted therapies, today announced clinical findings from Part 1 of a Phase 1b/2a clinical trial of the Company's first-in-class Ammonia Oxidizing...

08:00
Eiger BioPharmaceuticals, Inc. , focused on the development and commercialization of targeted therapies for rare diseases, announced today positive FDA guidance from a face to face discussion on the Hepatitis Delta Virus (HDV) program in February,...


20 mars 2018

16:05
SCYNEXIS, Inc. , a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced new pre-clinical data supporting the potential of SCY-078, the Company's lead...

14:59
Ocugen, Inc., une société spécialisée en ophtalmologie qui connaît une croissance rapide et développe un riche pipeline clinique de thérapies novatrices qui portent sur les troubles oculaires rares et retenant peu l'attention, a annoncé aujourd'hui...

13:00
goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that Worldwide Clinical Trials (Worldwide) has chosen goBalto's end-to-end platform for starting clinical trials....

12:50
The American Academy of Neurology and the American Brain Foundation are awarding an Illinois researcher the 2018 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases for his work in dementia research. David A. Bennett, MD, of Rush...

09:00
La Biocodex Microbiota Foundation (BMF, fondation du microbiote de Biocodex), un organisme fondé par Biocodex North America et dont la mission est d'inspirer la création de projets...

09:00
The Biocodex Microbiota Foundation (BMF), an organization founded by Biocodex North America and dedicated to inspiring scientific projects that explore the structure of microbiota, has announced two winners ? Dr. Rashim Singh from the...

08:50
Therapix Biosciences Ltd. ("Therapix" or the "Company"), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today that the U.S. Food and...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16